Product Code: ETC8846157 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Multi-infarct dementia, a type of vascular dementia, is increasingly being diagnosed among the aging population in the Philippines. The market focuses on symptom management using cognitive enhancers, lifestyle interventions, and preventive cardiovascular care, with growing demand for elderly healthcare services.
The Philippines Multi-Infarct Dementia (MID) Market is growing as awareness of neurodegenerative diseases increases and the aging population continues to rise. MID, caused by multiple strokes affecting brain function, requires effective diagnosis and treatment to manage symptoms and improve quality of life. With advancements in diagnostic tools and medications for dementia-related conditions, the market for MID treatments is expanding, supported by an increase in healthcare investments and an emphasis on improving elderly care in the country.
The market for multi-infarct dementia (MID) treatment in the Philippines faces challenges related to the lack of early diagnosis and the limited availability of specialized treatments. There is a general lack of awareness about dementia, particularly MID, among both the public and healthcare providers, which results in delayed diagnosis and suboptimal treatment. Additionally, the high cost of dementia care and medications makes it difficult for many patients to access necessary treatments, especially in rural areas.
The multi-infarct dementia market in the Philippines offers opportunities due to the aging population and the increasing prevalence of dementia-related conditions. Investment in early diagnosis tools, including imaging and biomarker tests, will be crucial in managing multi-infarct dementia. Companies can also invest in the development of pharmacological treatments aimed at improving cognitive function and slowing the progression of the disease. Additionally, healthcare providers can focus on creating awareness and providing specialized care for dementia patients, particularly in rural areas where access to healthcare services may be limited.
In the Philippines, the government has prioritized the awareness and treatment of multi-infarct dementia, a condition caused by multiple small strokes in the brain. Public health initiatives aim to educate the public about the importance of stroke prevention and the early identification of dementia symptoms. The Department of Health (DOH) works with healthcare providers to ensure that patients with multi-infarct dementia receive appropriate care, including cognitive therapies and medications. Efforts are also underway to improve access to specialized diagnostic tools for the condition.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Multi-Infarct Dementia Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Multi-Infarct Dementia Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Multi-Infarct Dementia Market - Industry Life Cycle |
3.4 Philippines Multi-Infarct Dementia Market - Porter's Five Forces |
3.5 Philippines Multi-Infarct Dementia Market Revenues & Volume Share, By Cause, 2021 & 2031F |
3.6 Philippines Multi-Infarct Dementia Market Revenues & Volume Share, By Pharmacological Treatment, 2021 & 2031F |
4 Philippines Multi-Infarct Dementia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Multi-Infarct Dementia Market Trends |
6 Philippines Multi-Infarct Dementia Market, By Types |
6.1 Philippines Multi-Infarct Dementia Market, By Cause |
6.1.1 Overview and Analysis |
6.1.2 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Cause, 2021- 2031F |
6.1.3 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Anemia, 2021- 2031F |
6.1.4 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Brain Tumor, 2021- 2031F |
6.1.5 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Chronic Infection, 2021- 2031F |
6.1.6 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Depression, 2021- 2031F |
6.1.7 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Thyroid Disease, 2021- 2031F |
6.1.8 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Vitamin Deficiency, 2021- 2031F |
6.1.9 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Multi-Infarct Dementia Market, By Pharmacological Treatment |
6.2.1 Overview and Analysis |
6.2.2 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Cheis, 2021- 2031F |
6.2.3 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Donepezil, 2021- 2031F |
6.2.4 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Galantamine, 2021- 2031F |
6.2.5 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Rivastigmine, 2021- 2031F |
6.2.6 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Memantine, 2021- 2031F |
6.2.7 Philippines Multi-Infarct Dementia Market Revenues & Volume, By Nimodipine, 2021- 2031F |
7 Philippines Multi-Infarct Dementia Market Import-Export Trade Statistics |
7.1 Philippines Multi-Infarct Dementia Market Export to Major Countries |
7.2 Philippines Multi-Infarct Dementia Market Imports from Major Countries |
8 Philippines Multi-Infarct Dementia Market Key Performance Indicators |
9 Philippines Multi-Infarct Dementia Market - Opportunity Assessment |
9.1 Philippines Multi-Infarct Dementia Market Opportunity Assessment, By Cause, 2021 & 2031F |
9.2 Philippines Multi-Infarct Dementia Market Opportunity Assessment, By Pharmacological Treatment, 2021 & 2031F |
10 Philippines Multi-Infarct Dementia Market - Competitive Landscape |
10.1 Philippines Multi-Infarct Dementia Market Revenue Share, By Companies, 2024 |
10.2 Philippines Multi-Infarct Dementia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |